Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01953224
Other study ID # 13-0285
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2014
Est. completion date November 2016

Study information

Verified date April 2018
Source The University of Texas Medical Branch, Galveston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to test an intervention that uses a mobile game to encourage increased physical activity among adults.


Description:

Physical activity reduces cardiometabolic risk factors. Unfortunately, a majority of adults do not meet activity recommendations. Though walking is a preferred method for activity with proven effectiveness, motivating sustained adherence to activity goals is difficult. "Gamification" using technology-based tools holds promise for motivating increased adherence to physical activity goals. Gamification occurs when elements from video games (such as leaderboards, badges, and progression through a virtual narrative) are integrated into non-game applications. Game elements may motivate faster, longer, and/or more frequent walking by making walking and self-monitoring more enjoyable. In the proposed research the investigators seek to test the feasibility and acceptability of a technology-based intervention that "gamifies" physical activity using technology. The investigators will randomize 40 inactive overweight adults (20 women, aged 18 - 69) to either an intervention group or a wait-list control. (Note: 10 additional participants will be recruited for a pre-pilot one-arm test of the intervention to ensure that the mobile devices, cellular service, game, etc. are working correctly.) The intervention will consist primarily of provision of a mobile device loaded with a narrative-based walking application ("app"). Participants will be instructed to use the app to achieve activity goals increasing from 60 to 150 or more minutes per week. The app uses global positioning systems and accelerometry to track exercise duration and intensity. Investigators will call participants weekly for brief counseling and technical support. The intervention will last 12 weeks. Primary outcomes are process measures of feasibility and acceptability, including attrition, reasons for drop-out, adherence to use of the app, exposure to calls, and any adverse events. The investigators will also compare behavioral (physical activity), weight-related (weight, body composition), and health outcomes (fitness, blood pressure) in the intervention group to the wait-list control. Finally, theory-based intermediate variables, such as self-efficacy, intrinsic motivation, and self-regulation, will also be investigated. This study will provide crucial information regarding the promise of gamified apps and will lay a foundation for a larger research program in technology-based cardiovascular health promotion.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date November 2016
Est. primary completion date November 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria:

1. Age between 18 and 69 years old

2. BMI is between 25 kg/m2 and 35 kg/m2

3. Able to read and understand English

4. Able to read words in standard applications on a mobile device 5" large

5. Able to walk for exercise

6. Able to find transportation to the study location

7. Willing to use a smartphone provided by the study to participate

8. Willing to listen to a potentially scary or sad story that includes violence

9. Willing to share basic information on walks with other participants via a social network

Exclusion Criteria:

1. (If female) currently pregnant or nursing or plan to become pregnant in the next 6 months

2. Report a heart condition, chest pain during periods of activity or rest, or loss of consciousness on the Physical Activity Readiness Questionnaire (PAR-Q, items 1 - 4). Reporting taking medicine for blood pressure on this questionnaire will require a doctor's note to participate.

3. Unable to walk for exercise (self-report)

4. Report current symptoms of alcohol or substance dependence

5. Plans to move away from the Galveston-Houston area in the next 4 months or to be out of town for more than 1 week during the study period

6. Unwillingness to report drugs taken for comorbidities such as hypertension or diabetes

7. Takes medications for diabetes or thyroid issues

8. Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months

9. Participant is active (60 minutes of moderate-vigorous intensity activity per week or more)

10. Another member of the household is a participant or staff member on this trial

11. Currently a participant in a physical activity or weight loss research trial

12. Recently (less than six months ago) completed a physical activity or weight loss research trial

13. Recently (less than six months ago) lost more than 5% of their body weight

14. Report a history of orthopedic complications that would prevent optimal participation in the physical activities prescribed (e.g., heel spurs, severe arthritis - may be eligible, but a doctor's note will be required)

15. Current smoker

16. Currently uses Zombies, Run! for exercise

Study Design


Intervention

Behavioral:
Game-based intervention
Investigators will provide participants with a smartphone and required accessories (gift card for downloading the game application and music, headphones, armband). The game, "Zombies, Run!" encourages walking/jogging by playing music interspersed with a continuous narrative. Periodic "zombie chases" encourage brief interval training. Participants will set goals to increase their activity and receive weekly brief counseling phone calls to provide feedback.
Device:
Smartphone


Locations

Country Name City State
United States The University of Texas Medical Branch Galveston Texas

Sponsors (2)

Lead Sponsor Collaborator
The University of Texas Medical Branch, Galveston American Heart Association

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of Participants Who Drop Out of the Study From Baseline to 12 Weeks We will investigate the number of participants who drop out of the intervention group in comparison to the control group and to norms for similar studies 12 weeks
Other Acceptability Acceptability will be self-reported using a variety of items taken from previous studies of physical activity interventions and usability 12 weeks
Other Frequency of App Use Over 12 Weeks Based on objective measures taken from individual game accounts, we will determine the discrete number of uses of the game app 12 weeks
Other Number of Counseling Calls Completed From Baseline to 12 Weeks Based on counselor logs, we will determine the number of counseling phone calls completed for each participant 12 weeks
Other Number of Participants With Adverse Events We will inquire about potential adverse events during counseling calls and assessment visits. Discrete events will be summed, and the number of participants with events will be summed. 12 weeks
Primary Change in Physical Activity From Baseline to 12 Weeks Minutes of physical activity measured over a 7 day period. Baseline values were carried forward for participants lost to followup. Baseline to 12 weeks
Secondary Change in Physical Fitness From Baseline to 12 Weeks Maximal treadmill test to measure fitness (operationalized as the amount of oxygen used by the body during maximal effort). Baseline values were carried forward for participants lost to followup. Baseline to 12 weeks
Secondary Change in Body Fat Percentage From Baseline to 12 Weeks We will use dual x-ray absorptiometry to measure body fat percentage. Baseline values were carried forward for participants lost to followup. Baseline to 12 weeks
Secondary Change in Blood Pressure From Baseline to 12 Weeks Systolic and diastolic blood pressure will be measured using standard methods. Baseline values were carried forward for participants lost to followup. Baseline to 12 weeks
Secondary Change in Weight From Baseline to 12 Weeks We will measure weight using a calibrated scale. Baseline values were carried forward for participants lost to followup. Baseline to 12 weeks
Secondary Change in Motivation From Baseline to 12 Weeks We will measure intrinsic motivation using the intrinsic regulation subscale from the Behavioral Regulation in Exercise Questionnaire-2. This measure uses a scale from 0 (not true for me) to 4 (very true for me). Positive changes indicate increases in intrinsic motivation over time. Baseline values were carried forward for participants lost to followup. Baseline to 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2